Concepedia
Statistics
Publications
92
Citations
9.6K
H-Index
46
Active since
1979
Affiliations
Cleveland Clinic(Current)
Eli Lilly (United States)
University of Minnesota
Montreal Heart Institute
Maryland Medical Research Institute
Byron J. Hoogwerf is an author at Cleveland Clinic specializing in medicine, diabetes mellitus, and diabetology.
Publications per year
1979–2020
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
Faramarz Ismail‐Beigi, Timothy E. Craven, Mary Ann Banerji et al. · The Lancet · 2010 · 1.4K citations
Medicine, Internal Medicine, Diabetology +14
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
John B. Buse, Michael A. Nauck, Thomas Först et al. · The Lancet · 2012 · 563 citations
Medicine, Endocrinology, Pharmacotherapy +13
Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
Rodica Pop‐Busui, Gregory W. Evans, Hertzel C. Gerstein et al. · Diabetes Care · 2010 · 535 citations · Full text
Medicine, Cardiology, Internal Medicine +17
Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes
John B. Buse, Richard M. Bergenstal, Leonard C. Glass et al. · Annals of Internal Medicine · 2011 · 506 citations
Medicine, Endocrinology, Pharmacology +17
The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes
Bernard Zinman, Byron J. Hoogwerf, Santiago Durán García et al. · Annals of Internal Medicine · 2007 · 429 citations
Medicine, Pharmacology, Pharmacotherapy +17
1–5 of 92